Anixa Biosciences, Inc. Stock Performance

Open $2.90	Prev. Close $2.95	Circuit Range N/A
Day Range $2.89 - $2.92	Year Range $2.37 - $5.43	Volume 5,034
Average Traded $2.90

Anixa Biosciences, Inc. Share Price Today

As of 9 October 2026, Anixa Biosciences, Inc.'s share price is $2.90. The stock opened at $2.90, compared to its previous close of $2.95. During today's trading session, Anixa Biosciences, Inc.'s share price traded between $2.89 and $2.92, with an average price of $2.91. Over the past 52 weeks, the stock has recorded a high of $5.43 and a low of $2.37. In terms of performance, Anixa Biosciences, Inc.'s share price has declined by 1.86% over the last six months and is down 29.78% on a year-on-year basis.

Anixa Biosciences, Inc. Share Price Chart

$2.89$2.92

Anixa Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap $94116.60	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.30	Revenue (TTM) $0.00	Return On Equity (TTM) -71.74%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY 3.33%

Anixa Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$2.70	-$2.57	-$2.52	-$2.61
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	4.81%	1.95%	-3.57%

Anixa Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.21	$0.00	$0.00
Net Profit	-$13.60	-$9.81	-$12.55	-$10.93
Net Profit Margin	N/A	-4671.43%	N/A	N/A
Income Change	N/A	27.87%	-27.93%	12.91%

About Anixa Biosciences, Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Anixa Biosciences, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$2.90	$2.91	-0.34%
Sep 2026	$3.33	$2.92	-19.11%
Aug 2026	$3.45	$3.61	+4.79%
Jul 2026	$2.81	$3.44	+21.52%
Jun 2026	$2.70	$2.83	+3.85%
May 2026	$2.99	$2.73	-7.61%
Apr 2026	$2.76	$2.96	+13.22%
Mar 2026	$2.94	$2.61	-12.12%
Feb 2026	$3.02	$2.97	-2.14%
Jan 2026	$3.17	$3.04	-1.46%
Dec 2025	$4.54	$3.08	-32.82%
Nov 2025	$4.00	$4.58	+11.02%

ANIX Share Price FAQs

What is Anixa Biosciences, Inc. share price today?

Anixa Biosciences, Inc. share price today is $2.90 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Anixa Biosciences, Inc. stock?

The 52 week high of Anixa Biosciences, Inc. stock is $5.43, while the 52 week low is $2.37 as of 9 Oct '26.

What is ANIX's market capitalisation today?

ANIX market capitalisation is $94116.60 as of October 9, 2026, at 4:48 pm IST.

What is ANIX's net income for the last quarter?

ANIX's net income for the last quarter is -2.61B USD.

What is the 5 year returns of ANIX?

The 5 year returns of ANIX is -39.20% as on 9 Oct '26.

What is the high & low stock price of ANIX today?

ANIX stock price hit a high of $2.92 and low of $2.89 as of 9 Oct '26.

Can I buy ANIX shares in India?

Yes. You can buy ANIX in India by opening an international trading account.